These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 28987395)

  • 1. Abciximab/Heparin Therapy for Left Ventricular Assist Device Implantation in Patients With Heparin-Induced Thrombocytopenia.
    Lee CL; Colombo PC; Eisenberger A; Diuguid D; Jennings DL; Han J; Salna MP; Takeda K; Kurlansky PA; Yuzefpolskaya M; Garan AR; Naka Y; Takayama H
    Ann Thorac Surg; 2018 Jan; 105(1):122-128. PubMed ID: 28987395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HeartMate II implantation in patients with heparin-induced thrombocytopenia type II.
    Meyer AL; Malehsa D; Kuehn C; Bara C; Gras C; Hafer C; Haverich A; Strüber M
    Ann Thorac Surg; 2009 Aug; 88(2):674-5. PubMed ID: 19632444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implantation of left ventricular assist devices under extracorporeal life support in patients with heparin-induced thrombocytopenia.
    Hillebrand J; Sindermann J; Schmidt C; Mesters R; Martens S; Scherer M
    J Artif Organs; 2015 Dec; 18(4):291-9. PubMed ID: 26044781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of cangrelor with heparin for left ventricular assist device implantation in a patient with acute heparin-induced thrombocytopenia.
    Gernhofer YK; Ross M; Khoche S; Pretorius V
    J Cardiothorac Surg; 2018 Apr; 13(1):30. PubMed ID: 29665860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low thromboembolic risk for patients with the Heartmate II left ventricular assist device.
    John R; Kamdar F; Liao K; Colvin-Adams M; Miller L; Joyce L; Boyle A
    J Thorac Cardiovasc Surg; 2008 Nov; 136(5):1318-23. PubMed ID: 19026822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of left ventricular assist device (HeartMate II): a Singapore experience.
    Lim CP; Sivathasan C; Tan TE; Lim CH; Kerk KL; Sim DK
    Artif Organs; 2014 Jul; 38(7):543-8. PubMed ID: 24392937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy.
    John R; Kamdar F; Liao K; Colvin-Adams M; Boyle A; Joyce L
    Ann Thorac Surg; 2008 Oct; 86(4):1227-34; discussion 1234-5. PubMed ID: 18805167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anticoagulative management of patients requiring left ventricular assist device implantation and suffering from heparin-induced thrombocytopenia type II.
    Christiansen S; Jahn UR; Meyer J; Scheld HH; Van Aken H; Kehrel BE; Hammel D
    Ann Thorac Surg; 2000 Mar; 69(3):774-7. PubMed ID: 10750760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Left ventricular assist device implantation after plasma exchange for heparin-induced thrombocytopenia.
    Koizumi S; Kohno H; Watanabe M; Iwahana T; Maeda T; Miyata S; Kobayashi Y; Matsumiya G
    J Artif Organs; 2018 Dec; 21(4):462-465. PubMed ID: 29938391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel Use of Cangrelor With Heparin During Cardiopulmonary Bypass in Patients With Heparin-Induced Thrombocytopenia Who Require Cardiovascular Surgery: A Case Series.
    Gernhofer YK; Banks DA; Golts E; Pretorius V
    Semin Thorac Cardiovasc Surg; 2020 Winter; 32(4):763-769. PubMed ID: 31610233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of minimal dose (< or =1,000 units) unfractionated heparin with abciximab in percutaneous coronary intervention.
    Denardo SJ; Davis KE; Reid PR; Tcheng JE
    Am J Cardiol; 2003 Jan; 91(1):1-5. PubMed ID: 12505562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treating Heparin-Induced Thrombocytopenia in Patients Undergoing HeartMate 3 Left Ventricular Assist Device Implantation.
    Eisenberger J; Somer S; Ram E; Nachum E; Frogal J; Levin S; Lavee J; Sternik L; Morgan J
    Isr Med Assoc J; 2023 Nov; 25(11):757-759. PubMed ID: 37980622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implantation of a left ventricular assist device in a patient with primary antiphospholipid syndrome.
    Meyer AL; Kuehn C; Gras C; Malehsa D; Bara C; Fischer S; Haverich A; Strüber M
    Ann Thorac Surg; 2008 Aug; 86(2):639-40. PubMed ID: 18640348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Post-operative heparin may not be required for transitioning patients with a HeartMate II left ventricular assist system to long-term warfarin therapy.
    Slaughter MS; Naka Y; John R; Boyle A; Conte JV; Russell SD; Aaronson KD; Sundareswaran KS; Farrar DJ; Pagani FD
    J Heart Lung Transplant; 2010 Jun; 29(6):616-24. PubMed ID: 20400335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety of immediate reversal of anticoagulation by protamine to reduce bleeding complications after infarct artery stenting for acute myocardial infarction and adjunctive abciximab therapy.
    Parodi G; De Luca G; Moschi G; Bellandi B; Valenti R; Migliorini A; Carrabba N; Antoniucci D
    J Thromb Thrombolysis; 2010 Nov; 30(4):446-51. PubMed ID: 20571920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bivalirudin anticoagulation for left ventricular assist device implantation on an extracorporeal life support system in patients with heparin-induced thrombocytopenia antibodies.
    Ljajikj E; Zittermann A; Morshuis M; Börgermann J; Ruiz-Cano M; Schoenbrodt M; Gummert J; Koster A
    Interact Cardiovasc Thorac Surg; 2017 Dec; 25(6):898-904. PubMed ID: 29049666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Argatroban anticoagulation for heparin induced thrombocytopenia in patients with ventricular assist devices.
    Pappalardo F; Scandroglio AM; Potapov E; Stepanenko A; Maj G; Krabatsch T; Zangrillo A; Koster A; Hetzer R
    Minerva Anestesiol; 2012 Mar; 78(3):330-5. PubMed ID: 22357371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Argatroban as a primary or secondary postoperative anticoagulant in patients implanted with ventricular assist devices.
    Samuels LE; Kohout J; Casanova-Ghosh E; Hagan K; Garwood P; Ferdinand F; Goldman SM
    Ann Thorac Surg; 2008 May; 85(5):1651-5. PubMed ID: 18442558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anticoagulation during cardiopulmonary bypass in patients with heparin-induced thrombocytopenia type II and renal impairment using heparin and the platelet glycoprotein IIb-IIIa antagonist tirofiban.
    Koster A; Kukucka M; Bach F; Meyer O; Fischer T; Mertzlufft F; Loebe M; Hetzer R; Kuppe H
    Anesthesiology; 2001 Feb; 94(2):245-51. PubMed ID: 11176088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heparin-induced thrombocytopenia in left ventricular assist device bridge-to-transplant patients.
    Schroder JN; Daneshmand MA; Villamizar NR; Petersen RP; Blue LJ; Welsby IJ; Lodge AJ; Ortel TL; Rogers JG; Milano CA
    Ann Thorac Surg; 2007 Sep; 84(3):841-5; discussion 845-6. PubMed ID: 17720387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.